Dataset Information

Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.

ABSTRACT: A novel phenyl acetamide series of short-acting T-type calcium channel antagonists has been identified and evaluated using in vitro and in vivo assays. Heterocycle substitutions of the 4-position of the phenyl acetamides afforded potent and selective antagonists that exhibited desired short plasma half-lives across preclinical species. Lead compound TTA-A8 emerged as a compound with excellent in vivo efficacy as indicated by its significant modulation of rat sleep architecture in an EEG telemetry model, favorable pharmacokinetic properties, and excellent preclinical safety. TTA-A8 recently progressed into human clinical trials, and in line with our predictions, preliminary studies (n = 12) with a 20 mg oral dose afforded a high C max of 1.82 ± 0.274 ?M with an apparent terminal half-life of 3.0 ± 1.1 h.

SUBMITTER: Yang ZQ

PROVIDER: S-EPMC4007914 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.

Yang Zhi-Qiang ZQ Schlegel Kelly-Ann S KA Shu Youheng Y Reger Thomas S TS Cube Rowena R Mattern Christa C Coleman Paul J PJ Small Jim J Hartman George D GD Ballard Jeanine J Tang Cuyue C Kuo Yuhsin Y Prueksaritanont Thomayant T Nuss Cindy E CE Doran Scott S Fox Steve V SV Garson Susan L SL Li Yuxing Y Kraus Richard L RL Uebele Victor N VN Taylor Adekemi B AB Zeng Wei W Fang Wei W Chavez-Eng Cynthia C Troyer Matthew D MD Luk Julie Ann JA Laethem Tine T Cook William O WO Renger John J JJ Barrow James C JC

ACS medicinal chemistry letters 20100824 9

A novel phenyl acetamide series of short-acting T-type calcium channel antagonists has been identified and evaluated using in vitro and in vivo assays. Heterocycle substitutions of the 4-position of the phenyl acetamides afforded potent and selective antagonists that exhibited desired short plasma half-lives across preclinical species. Lead compound TTA-A8 emerged as a compound with excellent in vivo efficacy as indicated by its significant modulation of rat sleep architecture in an EEG telemetr ...[more]

PMID: 24900239

Dataset Information

Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.

Publications

Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Metabolism-guided design of short-acting calcium-sensing receptor antagonists.
| S-EPMC4007832 | biostudies-other

Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to calcium channel antagonists
2020-02-21 | GSE122763 | GEO

FM dyes enter via a store-operated calcium channel and modify calcium signaling of cultured astrocytes.
| S-EPMC2799853 | biostudies-literature

Pore architecture of the ORAI1 store-operated calcium channel.
| S-EPMC2841875 | biostudies-literature

Antagonists of the TMEM16A calcium-activated chloride channel modulate airway smooth muscle tone and intracellular calcium.
| S-EPMC4543527 | biostudies-literature

Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to calcium channel antagonists [C790 cells]
2020-02-21 | GSE122399 | GEO

Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to calcium channel antagonists [4434 cells]
2020-02-21 | GSE122402 | GEO

Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel Antagonists.
| S-EPMC4007971 | biostudies-literature

Sensory transduction channel subunits, tax-4 and tax-2, modify presynaptic molecular architecture in C. elegans.
| S-EPMC3168524 | biostudies-literature

Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity.
| S-EPMC5366925 | biostudies-literature